Clinical trial

Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.

NCT03047278

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-11-01

PhasePHASE4

Study timeline

Study start (actual)2015-11-01Date precision: day

Registry last updated2019-07-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neuropathic Painunresolved

Type 2 Diabetes Mellitusunresolved

Diabetic Neuropathy, Painfulunresolved

Interventions

Serial Blood SamplesPROCEDURE

Serial Urine SamplesPROCEDURE

Gabapentin 300 mgDRUG · verified · RxNorm: gabapentin 300 MG

Cetirizine Hydrochloride 10 mgDRUG · verified · RxNorm: cetirizine hydrochloride 10 MG

Sponsors & collaborators

Natalia Valadares de Moraeslead sponsor

University of Sao Paulocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03047278 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.